Business Context and Reporting Period
Lifecore Biomedical, Inc. (LFCR) filed this Form 8-K on September 22, 2025, to disclose the approval of a new cash incentive pay plan. The filing addresses a transition period from May 26, 2025, through December 31, 2025, necessitated by the Company's change from a fiscal year ending the last Sunday of May to a calendar year ending December 31.
Key Financial Metrics
This filing does not report specific financial results such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation arrangements and performance metrics definitions.
Material Changes
- Fiscal Year Change: The Company has shifted its fiscal year-end to December 31, creating a seven-month transition period for 2025.
- Compensation Plan Termination: The previously approved "2026 Bonus Plan" (for the fiscal year ending May 31, 2026) has been terminated and replaced by the "CY 2025 Transition Period Bonus Plan."
- Executive Bonus Structure: New performance objectives were established for CEO Paul Josephs, CFO Ryan D. Lake, and Chief Legal and Administration Officer Thomas D. Salus.
Guidance, Outlook, and Management Commentary
The Compensation Committee approved a bonus plan weighted as follows:
- 80% Company Financial Performance: Based on Adjusted EBITDA and Total Revenue. A minimum Adjusted EBITDA threshold must be met to earn any bonus. Maximum payout is capped at 200% of the target opportunity.
- 10% Individual Performance Objectives.
- 10% Company Business Goals: Four equally weighted objectives.
Target Bonus Percentages of Base Salary:
- Paul Josephs (CEO): 100%
- Ryan D. Lake (CFO): 60%
- Thomas D. Salus (Chief Legal and Administration Officer): 50% (Note: Mr. Salus is entitled to 125% of any bonus actually earned per his employment agreement).
Definitions and Conditions:
- Adjusted EBITDA: Excludes non-normalized costs such as derivative fair value changes, financing fees, restructuring costs, and activist settlement costs, but includes the cost of the bonuses themselves.
- Clawback Policy: All payments are subject to the Company's Compensation Recoupment Policy adopted on October 2, 2023.
- Employment Requirement: Executives must be employed at the end of the fiscal year and on the payment date to receive bonuses.
Investor Verification Checklist
- Verify the specific Adjusted EBITDA and Total Revenue targets set for the transition period, as these are not disclosed in this filing.
- Confirm the impact of the fiscal year change on future quarterly reporting schedules and comparability.
- Review the Company's Compensation Recoupment Policy to understand specific clawback triggers.
- Monitor subsequent filings for the actual financial performance against the minimum thresholds required to trigger executive bonuses.